Overview
Dr. O’Shea sees patients with all movement disorders including Parkinson’s disease, Huntington’s disease, atypical parkinsonism, tremor, ataxia, chorea and dystonia. She specializes in Deep Brain Stimulation (DBS) for movement disorders, including patient selection, evaluation, intra-operative assessments, and post-operative programming. She is also skilled in neurotoxin injections for movement disorders and spasticity.
Dr. O’Shea’s research interests include investigating prodromal biomarkers of Parkinson’s disease and the effects of neurotoxicant exposure on the development of neurodegenerative disease. She also leads several clinical trials for Parkinson’s disease and Huntington’s disease. Her research has previously been funded by the American Parkinson’s Disease Association (APDA). She currently runs clinical trials, with particular focus on Huntington's disease. She also is the Columbia site principal investigator for the Michael J. Fox Foundation Parkinson's Progression Marker Initiative.
Dr. O’Shea is a member of the International Parkinson and Movement Disorder Society (MDS) and American Academy of Neurology (AAN). She is a credentialed member of the Parkinson Study Group (PSG) and Huntington Study Group (HSG). She was also appointed to serve on the exam writing committee for the American Board of Psychiatry and Neurology (ABPN).
Dr. Sarah O’Shea is an Assistant Professor of Neurology in the Columbia University Vagelos College of Physician and Surgeons. She obtained her medical doctorate at the University of Illinois. She completed her residency training and served as Chief Resident in Neurology at the University of Iowa Hospitals and Clinics. She then completed her fellowship training in Movement Disorders at Columbia University Medical Center and completed the Neuroepidemiology Training Program (NETP, Master of Science in Epidemiology) during her training at Columbia University. Prior to joining the faculty at Columbia, Dr. O’Shea was an Assistant Professor of Neurology in the Division of Movement Disorders at Boston University School of Medicine.
Dr. O'Shea is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, and Deep Brain Stimulation.
Her clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Frontotemporal Dementia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- POS
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
710 W 168th St, New York, NY 10033
Additional Areas of Focus
Dr. O'Shea has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Icahn School Of Medicine At Mount Sinai
Georges Naasan is a Neurologist in New York, New York. Dr. Naasan is rated as a Distinguished provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Frontotemporal Dementia, Cerebellar Degeneration, Lewy Body Dementia (LBD), and Primary Progressive Aphasia.
Eyad Nayal is a Neurologist in Wayne, New Jersey. Dr. Nayal is rated as a Distinguished provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Primary Progressive Aphasia, Frontotemporal Dementia, Progressive Myoclonic Epilepsy, and Unverricht-Lundborg Syndrome. Dr. Nayal is currently accepting new patients.
Northwell Health Physician Partners Neuroscience Institute At Great Neck
Luca Giliberto is a Neurologist in Great Neck, New York. Dr. Giliberto is rated as an Advanced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Primary Progressive Aphasia, Frontotemporal Dementia, Memory Loss, and Cerebellar Degeneration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Movement DisordersDr. O'Shea isAdvanced. Learn about Movement Disorders.
- Parkinson's DiseaseDr. O'Shea isAdvanced. Learn about Parkinson's Disease.
- Experienced
- Alzheimer's DiseaseDr. O'Shea isExperienced. Learn about Alzheimer's Disease.
- Congenital Cardiovascular ShuntDr. O'Shea isExperienced. Learn about Congenital Cardiovascular Shunt.
- DementiaDr. O'Shea isExperienced. Learn about Dementia.
- Developmental Dysphasia FamilialDr. O'Shea isExperienced. Learn about Developmental Dysphasia Familial.
- Drug Induced DyskinesiaDr. O'Shea isExperienced. Learn about Drug Induced Dyskinesia.
- Essential TremorDr. O'Shea isExperienced. Learn about Essential Tremor.